Cowen Inc’s NanoViricides NNVC Stock Holding History

Cowen Inc’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18,688	Closed	–	–	428
2018 Q4	$0	Hold	18,688	–	–	﹤0.01%	426
2018 Q3	$0	Hold	18,688	–	–	﹤0.01%	594
2018 Q2	$0	Buy	+18,688	New	+$229K	﹤0.01%	525
2017 Q4	–	Sell	-18,688	Closed	–	–	332
2017 Q3	$0	Hold	18,688	–	–	﹤0.01%	278
2017 Q2	$0	Buy	+18,688	New	+$462K	﹤0.01%	342
2017 Q1	–	Sell	-18,688	Closed	–	–	286
2016 Q4	$0	Buy	+18,688	New	+$498K	﹤0.01%	284
2016 Q3	–	Sell	-18,688	Closed	-$1K	–	254
2016 Q2	$1K	Hold	18,688	–	–	﹤0.01%	205
2016 Q1	$12K	Buy	+18,688	New	+$725K	﹤0.01%	249

Other funds holding NNVC

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PTB

Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

Cowen Inc's NNVC Position: Q1 2019 in Review

Cowen Inc sold out of NanoViricides (NNVC) in Q1 2019, closing a stake of 18,688 shares.

Cowen Inc first reported a position in NNVC in Q1 2016 and held it in 8 quarters. The position peaked at $12K in Q1 2016. 39 funds tracked by Wall St. Rank hold NNVC as of Q1 2019.

Cowen Inc reported no remaining NanoViricides position as of Q1 2019 after selling out during the quarter.
Cowen Inc sold 18,688 NanoViricides shares in Q1 2019.
Cowen Inc first reported a position in NanoViricides in Q1 2016 and held it in 8 quarters.
Cowen Inc's NanoViricides position peaked at $12K in Q1 2016.
39 funds tracked by Wall St. Rank held NanoViricides as of Q1 2019.

Based on Cowen Inc's 13F filing for Q1 2019, filed 14 May 2019.